HomeNDC LookupRxCUI directory › RxCUI 199351

Trandolapril 2 MG Oral Tablet — RxCUI 199351

RxNorm drug concept · Semantic clinical drug
RxCUI 199351 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 22 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199351
Official nameTrandolapril 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped22
Reported Medicaid activity (SDUD)104 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trandolapril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trandolapril is used for two main things. First, it treats high blood pressure — it can be used on its own or paired with other blood pressure medicines. Second, it's used after a...
  • Yes, a dry, persistent cough is the most commonly reported side effect of trandolapril — it showed up in about 1 in 5 patients in heart failure trials. It's a known quirk of the wh...
  • I've heard ACE inhibitors cause a cough. Is that true with this one?
  • No — trandolapril is not safe during pregnancy and carries a serious boxed warning because of it. Using it during the second or third trimester can damage the baby's kidneys, cause...
📖 Read our full Trandolapril guide →

🕸️ Concept Web — How Trandolapril 2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trandolapril 2 MG Oral Tablet RxCUI 199351

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Trandolapril 38454
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trandolapril Oral Tablet 374177
    • Trandolapril Oral Product 1162758
    • Trandolapril Pill 1162759
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Trandolapril 2 MG 316847

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trandolapril 2 MG SCDC · 316847
  • Trandolapril Oral Tablet SCDF · 374177
  • Trandolapril Oral Product SCDG · 1162758
  • Trandolapril Pill SCDG · 1162759

📦 FDA Products & Package NDCs

14 products · 22 package NDCs
22 package NDCs map to RxCUI 199351 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42806-0052-01 100 TABLET in 1 BOTTLE (42806-052-01) Trandolapril Epic Pharma, LLC 2015-03-31
42806-0052-10 1000 TABLET in 1 BOTTLE (42806-052-10) Trandolapril Epic Pharma, LLC 2015-03-31
42806-0053-01 100 TABLET in 1 BOTTLE (42806-053-01) Trandolapril Epic Pharma, LLC 2015-03-31
42806-0053-10 1000 TABLET in 1 BOTTLE (42806-053-10) Trandolapril Epic Pharma, LLC 2015-03-31
42806-0054-01 100 TABLET in 1 BOTTLE (42806-054-01) Trandolapril Epic Pharma, LLC 2015-03-31
42806-0054-10 1000 TABLET in 1 BOTTLE (42806-054-10) Trandolapril Epic Pharma, LLC 2015-03-31
57237-0089-01 100 TABLET in 1 BOTTLE (57237-089-01) Trandolapril Rising Pharma Holdings, Inc. 2007-06-12
57237-0090-01 100 TABLET in 1 BOTTLE (57237-090-01) Trandolapril Rising Pharma Holdings, Inc. 2007-06-12
57237-0091-01 100 TABLET in 1 BOTTLE (57237-091-01) Trandolapril Rising Pharma Holdings, Inc. 2007-06-12
63629-8003-01 30 TABLET in 1 BOTTLE (63629-8003-1) Trandolapril Bryant Ranch Prepack 2019-05-02
63629-8003-02 90 TABLET in 1 BOTTLE (63629-8003-2) Trandolapril Bryant Ranch Prepack 2022-02-09
65862-0164-01 100 TABLET in 1 BOTTLE (65862-164-01) Trandolapril Aurobindo Pharma Limited 2007-06-12
65862-0164-99 1000 TABLET in 1 BOTTLE (65862-164-99) Trandolapril Aurobindo Pharma Limited 2007-06-12
65862-0165-01 100 TABLET in 1 BOTTLE (65862-165-01) Trandolapril Aurobindo Pharma Limited 2007-06-12
65862-0165-99 1000 TABLET in 1 BOTTLE (65862-165-99) Trandolapril Aurobindo Pharma Limited 2007-06-12
65862-0166-01 100 TABLET in 1 BOTTLE (65862-166-01) Trandolapril Aurobindo Pharma Limited 2007-06-12
65862-0166-99 1000 TABLET in 1 BOTTLE (65862-166-99) Trandolapril Aurobindo Pharma Limited 2007-06-12
68180-0566-01 100 TABLET in 1 BOTTLE (68180-566-01) Trandolapril Lupin Pharmaceuticals, Inc. 2007-06-11
68180-0567-01 100 TABLET in 1 BOTTLE (68180-567-01) Trandolapril Lupin Pharmaceuticals, Inc. 2007-06-11
68180-0568-01 100 TABLET in 1 BOTTLE (68180-568-01) Trandolapril Lupin Pharmaceuticals, Inc. 2007-06-11
71335-1431-01 30 TABLET in 1 BOTTLE (71335-1431-1) Trandolapril Bryant Ranch Prepack 2019-12-06
71335-1431-02 90 TABLET in 1 BOTTLE (71335-1431-2) Trandolapril Bryant Ranch Prepack 2024-05-30
Observed labelers: Aurobindo Pharma Limited (6) · Epic Pharma, LLC (6) · Bryant Ranch Prepack (4) · Lupin Pharmaceuticals, Inc. (3) · Rising Pharma Holdings, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.